MYC and Miyoshi myopathy: D089 significantly decreased cell proliferation in a time and dose responsive manner (Figure 1c), which correlated with a gradual decrease in MYC protein expression seen over a 24-h time course in MM cell lines treated at their IC50 (Figure 1d).